WordNet

an underactive thyroid gland; a glandular disorder resulting from insufficient production of thyroid hormones
from 63 million to 2 million years ago (同)Tertiary_period

PrepTutorEJDIC

甲状腺機能不全
(地質時代の)第三紀の / 《t-》第3[位]の / (地質時代の)第三紀

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 中枢性甲状腺機能低下症 central hypothyroidism
2. 甲状腺機能低下症の原因となる疾患 disorders that cause hypothyroidism
3. 甲状腺機能低下症の診断およびスクリーニング diagnosis of and screening for hypothyroidism
4. 下垂体機能低下症の臨床症状 clinical manifestations of hypopituitarism
5. 下垂体機能低下症の診断 diagnosis of hypopituitarism

English Journal

The effect of chewing gum on small-bowel transit time in capsule endoscopy: a prospective, randomized trial.

Ou G1, Svarta S1, Chan C1, Galorport C1, Qian H2, Enns R1.Author information 1Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada.2Centre for Health Evaluation and Outcome Sciences, University of British Columbia, Vancouver, British Columbia, Canada.AbstractBACKGROUND: Approximately 1 in 6 capsule endoscopies (CEs) does not visualize the entire small bowel at completion of the examination because of limited battery life.
Gastrointestinal endoscopy.Gastrointest Endosc.2014 Apr;79(4):630-6. doi: 10.1016/j.gie.2013.08.038. Epub 2013 Oct 7.
BACKGROUND: Approximately 1 in 6 capsule endoscopies (CEs) does not visualize the entire small bowel at completion of the examination because of limited battery life.OBJECTIVE: To determine whether chewing gum can reduce the small-bowel transit time and increase CE completion rates.DESIGN: Prospecti
PMID 24112594

Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study.

Huang CJ1, Chen PJ, Chang JW, Huang DF, Chang SL, Chen SA, Jap TS, Lin LY.Author information 1Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.AbstractBackground The incidence and risk factors of amiodarone-induced thyroid dysfunction are variable in the literature. Objective The aim of this study was to investigate the clinical and biochemical features and risk factors of amiodarone-induced thyroid dysfunction in Taiwan. Setting This study was conducted at a tertiary referral center for arrhythmia. Method Retrospective analysis of patients treated with amiodarone during the years 2008-2009 was performed. Main outcome measure Incidence and risk factors of amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH) were assessed. Results Of the 527 patients, 437 (82.9 %) remained euthyroid, 21 (4.0 %) developed AIT, and 69 (13.1 %) were affected with AIH. In univariate analysis, AIT was associated with younger age, and the risk factors for AIH included older age, higher baseline thyroid stimulating hormone (TSH) titer, lower baseline free T4 level, lower cumulative amiodarone dosage, and shorter amiodarone treatment duration. Cox regression analysis was performed to determine the different risk categories in the elderly population of age 65-74 (young-old), 75-84 (old-old), and ≥85 years old (oldest-old). Additionally increased risk of AIH was found in the groups of old-old (HR 2.09, 95 % CI 1.11-3.96) and oldest-old (HR 2.57, 95 % CI 1.21-4.75). In the multivariate analysis of risk factors for AIH, baseline TSH level (HR 1.38, 95 % CI 1.12-1.70) and cumulative amiodarone dosage (HR 0.95, 95 % CI 0.93-0.97) remained statistically significant. Conclusion AIH was much more common than AIT in Taiwan, an area with sufficient iodine intake. Higher baseline TSH level was the predominant independent risk factor for the development of AIH.
International journal of clinical pharmacy.Int J Clin Pharm.2014 Apr;36(2):405-11. doi: 10.1007/s11096-013-9910-9. Epub 2014 Feb 11.
Background The incidence and risk factors of amiodarone-induced thyroid dysfunction are variable in the literature. Objective The aim of this study was to investigate the clinical and biochemical features and risk factors of amiodarone-induced thyroid dysfunction in Taiwan. Setting This study was co
PMID 24515549

Non-operative management of giant omphalocele with topical povidone-iodine and powdered antibiotic combination: early experience from a tertiary centre.

Pandey V1, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V.Author information 1Department of Paediatric Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India, sunny.imsbhu@gmail.com.AbstractPURPOSE: The aim of the study was to evaluate topical povidone-iodine and topical powdered antibiotic combination (Polymyxin, Bacitracin and Neomycin) in initial non-operative management with delayed closure of the defect of giant omphaloceles.
Pediatric surgery international.Pediatr Surg Int.2014 Apr;30(4):407-11. doi: 10.1007/s00383-014-3479-9. Epub 2014 Feb 9.
PURPOSE: The aim of the study was to evaluate topical povidone-iodine and topical powdered antibiotic combination (Polymyxin, Bacitracin and Neomycin) in initial non-operative management with delayed closure of the defect of giant omphaloceles.METHODS: A prospective study was conducted between July
PMID 24509569